Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBRV | AZN | AMGN | GILD | BMY |
| Company | Nabriva Therapeutics Plc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.4500 | 94.47 | 328.70 | 123.80 | 56.46 |
| High | 1.9000 | 94.52 | 331.60 | 125.07 | 56.56 |
| Low | 1.3500 | 93.51 | 326.90 | 122.10 | 55.62 |
| Latest | 1.4200 | 93.73 | 329.34 | 123.85 | 55.74 |
| Change | unch | -0.26 | -0.69 | +2.59 | -0.88 |
| % Change | unch | -0.28% | -0.21% | +2.14% | -1.55% |
| Volume | 717,200 | 3,554,197 | 1,181,004 | 2,359,999 | 3,578,325 |
| 20-Day Average Volume | 46,640 | 5,273,883 | 2,603,736 | 5,985,152 | 13,796,587 |
| Previous Close | 1.4200 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 93.09 | 329.08 | 122.85 | 54.92 |
| 20-Day Raw Stochastic | 12.73% | 62.39% | 43.78% | 63.68% | 72.39% |
| 20-Day Relative Strength | 42.54 | 56.41 | 51.84 | 51.98 | 60.94 |
| Weighted Alpha | -50.30 | +43.34 | +21.40 | +30.29 | +7.71 |
| Today's Opinion | 100% Sell | 100% Buy | 64% Buy | 72% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | -0.81% since 01/09/26 | +0.92% since 01/09/26 | +2.05% since 01/09/26 | -0.35% since 01/09/26 |
| Low | 1.3500 on 07/31/23 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.33 on 01/15/26 |
| High | 1.9000 on 07/31/23 | 96.43 on 01/14/26 | 332.50 on 01/15/26 | 125.07 on 01/16/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | +2.78% since 12/16/25 | +0.72% since 12/16/25 | +4.05% since 12/16/25 | +2.65% since 12/16/25 |
| Low | 1.3500 on 07/31/23 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 1.9000 on 07/31/23 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | +11.99% since 10/16/25 | +11.25% since 10/16/25 | +4.87% since 10/16/25 | +28.29% since 10/16/25 |
| Low | 1.3500 on 07/31/23 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 2.2400 on 05/19/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | +33.97% since 07/16/25 | +10.05% since 07/16/25 | +12.50% since 07/16/25 | +18.01% since 07/16/25 |
| Low | 1.2600 on 03/27/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 2.2400 on 05/19/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 291,505,472 | 177,714,880 | 150,444,864 | 115,264,336 |
| Shares Outstanding, K | 32,015 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 36,940,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -57,190,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 7,590,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -8,700,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.53 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 08/02/23 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.08 | 15.04 | 15.15 | 8.69 |